Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

Inclusion Criteria

• •Age ≥18 years at the time of signing the informed consent
• •Hospitalised in a participating site and receiving full inpatient treatment (at least 24h hospital stay)
• •Diagnosis of HFrEF according to the current guidelines of the European Society of Cardiology (ESC) with a left ventricular EF of ≤40% (as measured per echocardiography during the index hospital stay or within 3 months prior to index hospitalisation with available reports from imaging (ejection fraction) at the time of study inclusion)
• •Treated with a maximum of 2 of the indicated drug classes (ACE-I/ARNI/ARB, BB, MRA, SGLT2i) according to guideline recommendation (GDMT) at admission.
• •Signed and dated written informed consent prior to enrolment in the study
• •Willing and capable to fulfil requirements listed in the ICF